Tomislav Bulum

The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

Type 1 diabetes, metabolic syndrome and cardiovascular risk

Sarcopenia: a chronic complication of type 2 diabetes mellitus

Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus

Macrophages in immunoregulation and therapeutics

Obesity and inflammation: the linking mechanism and the complications

Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

The impact of hyperfiltration on the diabetic kidney

Diabetic Kidney Disease

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver

Insulin sensitivity modifies the relationship between thyroid function and lipid profile in euthyroid type 1 diabetic patients

Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria

Hyperfiltration in normoalbuminuric type 1 diabetic patients: relationship with urinary albumin excretion rate.

Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients

Decreased serum monocytes and elevated neutrophils as additional markers of insulin resistance in type 1 diabetes

Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes